We strive to significantly improve human health span and restore patients’ quality of life


Overcoming aging, curing cancer. Our vision is to deliver the best precision therapies for aging oncology patients


We are committed to patients, dedicated to innovation and driven by sound mechanism-based science

Anne Marinier

Chief Executive Officer

Anne has over 25 years of experience in medicinal chemistry. She co-founded and led IRIC’s Drug Discovery Unit, and identified UM171. Anne was previously CTO at ExCellThera and Group Leader in the Drug Discovery Research group at Bristol-Myers Squibb.

David Millette

Chair of the Board

David has over 20 years of business management and advisory services experience. He is currently Co-CEO & COO at ExCellThera and was previously Partner at Norton Rose Fulbright. David has a broad range of financial, legal and strategic experience in pharmaceuticals, life sciences and healthcare.

Guy Sauvageau

Board Member

Guy is an internationally recognized stem cell biologist and hematologist. He identified UM171. Guy also co-founded the Center for Cell Therapy of Montreal and the Quebec Leukemia Cell Bank. He is Co-Founder, as well as current Co-CEO & CSO at ExCellThera.

Elizabeth Douville

Board Member

Elizabeth is President & CEO of IRICoR, a Center of Excellence in Commercialization and Research specializing in drug discovery in oncology and related areas, based at IRIC/University of Montreal. She is also a member of the board of directors of ExCellThera.